Nuvation Bio NUVB Cash Flow Statement (2020-2026)

NYSE NUVB
$4.21 -0.14 (-3.22%)
As of: Nov 10, 2026 · 3:59 PM EST
Reported Financials

Nuvation Bio Quarterly Cash Flow Statement

Periods 27 quarters
Latest Sep 2026

Nuvation Bio reported cash from operations of -$38.60M and free cash flow of -$40.19M for the quarter ended Sep 2026, up 27.0% year over year. This cash flow statement covers 27 quarters of results from Mar 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-25.13M-21.29M-34.86M-27.20M-20.85M-21.73M-20.64M-19.65M-13.79M-14.79M-462.49M-41.21M-49.45M-53.24M-59.01M-55.79M-36.59M5.40M-62.84M-41.90M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.02M0.21M0.33M0.32M0.35M0.34M
Depreciation & Amortization (CF)Dep. & Amort.
0.06M0.05M0.05M0.06M0.05M0.06M0.06M0.06M0.06M0.06M0.24M0.16M0.22M0.31M0.36M0.53M0.54M0.54M0.54M0.58M
Share-based CompensationStock Comp.
2.80M3.58M4.79M2.94M4.99M4.84M5.52M5.43M3.72M5.04M9.57M7.48M10.19M7.85M12.03M8.02M7.99M9.03M10.46M10.07M
Gains from Sales and DivestituresGains Divest
-0.03M-0.02M-0.01M-0.01M0.01M-0.17M0.17M-0.03M0.00M0.00M
Gains from Investment SecuritiesGains Investment
1.09M-0.21M-0.69M-0.19M-0.13M-0.10M-0.10M0.01M0.04M0.00M-0.01M-0.01M0.01M0.00M0.00M0.00M0.01M0.01M-0.01M
Other non-cash itemsOther Non-Cash
-5.34M-6.32M-3.08M-0.46M0.16M-0.16M0.27M-0.38M2.99M-1.40M423.94M-0.53M-0.57M-0.31M-0.45M-0.61M-0.74M-3.79M9.47M
Change in Working Capital
Change in ReceivablesChange Receivables
0.12M-0.01M12.61M-12.31M2.28M5.63M7.75M6.65M5.10M8.72M
Change in InventoryChange Inventory
0.01M0.54M5.16M5.70M4.43M4.06M-4.56M
Change in Account PayablesChange Payables
-1.17M5.75M3.06M-9.73M-0.86M0.81M-0.37M-0.20M-0.16M0.23M-3.02M7.17M-6.03M4.19M11.88M-7.06M-5.88M12.96M-9.85M-2.64M
Change in Accrued ExpensesChange Accrued Exp.
3.99M-5.02M0.48M2.31M-0.10M-1.45M1.19M2.30M-2.06M1.51M-5.53M3.53M7.33M-8.94M0.11M8.58M12.60M-12.32M13.77M2.01M
Change in Other Operating AssetsOther Assets Change
-4.20M4.20M-0.04M-2.70M-1.28M-0.14M-0.15M0.03M-1.46M5.77M-3.55M5.01M1.81M1.00M7.84M-6.49M2.76M0.65M-2.11M5.57M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.16M0.00M
Other Working Capital ChangesOther WC Changes
4.05M-4.20M0.04M2.70M1.28M0.14M0.15M-1.39M-0.48M5.81M-2.31M-2.20M-4.33M0.97M-0.43M-1.31M-1.37M
Cash from OperationsCash from Ops.
-23.48M-24.93M-26.92M-28.09M-16.17M-19.33M-17.49M-16.16M-15.03M-15.70M-37.32M-31.09M-46.30M-42.63M-48.18M-52.90M-29.73M5.10M-43.00M-38.60M
Investing Activities
Capital ExpendituresCapex
0.14M0.01M0.20M0.10M0.07M0.01M0.02M0.02M0.01M0.03M0.15M-0.01M0.07M0.18M8.01M0.09M0.05M0.25M1.59M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.01M0.01M
Change in Property, Plant and EquipmentChange in PP&E
-0.14M-0.01M-0.20M-0.10M-0.06M-0.01M-0.02M-0.02M0.00M-0.03M-0.15M0.01M-0.07M-0.18M-8.01M-0.09M-0.05M-0.25M-1.59M
Acquisitions
0.00M
Net of Acquisitions & DivestmentsNet Acquisitions
0.00M
Purchase of InvestmentsInvestments Purchased
254.45M131.67M131.00M119.93M137.71M236.97M206.83M110.84M148.74M128.41M93.53M85.66M32.04M60.71M81.67M167.14M44.90M82.15M67.69M225.89M
Sale and Maturity of InvestmentsInvestments Sold
65.32M126.13M157.83M184.23M115.94M184.98M244.20M101.27M181.90M135.98M115.28M114.93M83.89M114.96M136.73M78.53M132.07M38.56M73.94M118.13M
Cash from Investing ActivitiesCash from Investing
-189.26M-5.55M-15.53M106.37M-21.83M-52.00M37.35M-9.59M33.16M7.54M34.27M29.12M51.77M54.18M54.88M-96.62M87.08M-43.64M5.99M-109.34M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
36.57M
Net Long-Term Debt Issued (Repaid)Net LT Debt
36.57M
Short-Term Debt issuancesST Debt Issuance
5.57M11.20M
Net Short-Term Debt Issued (Repaid)Net ST Debt
5.57M11.20M
Net Debt Issuances and RepaymentsNet Debt Issuance
5.57M11.20M36.57M
Change in Capital Stock
Common Stock IssuedStock Issued
0.23M0.31M0.06M0.26M0.31M0.30M-0.13M0.08M-0.12M0.02M1.82M1.67M0.52M1.08M0.23M0.56M6.93M0.91M2.25M7.95M
Net Shares Issued and RepurchasedNet Shares Issued
0.23M0.31M0.06M0.26M0.31M0.30M-0.13M0.08M-0.12M0.02M1.82M1.67M0.52M1.08M0.23M0.56M6.93M0.91M2.25M7.95M
Net Equity Issued and RepurchasedNet Equity Issued
0.23M0.31M0.06M0.26M0.31M0.30M-0.13M0.08M-0.12M0.02M1.82M1.67M0.52M1.08M0.23M0.56M6.93M0.91M2.25M7.95M
Other financing activities (as filed)
-6.32M-3.21M-7.63M-0.53M-6.77M0.01M-11.20M-10.46M-0.07M
Cash from Financing ActivitiesCash from Financing
0.54M4.26M-3.60M0.26M0.41M0.30M0.13M0.08M0.12M0.02M2.75M-1.54M-0.90M0.55M193.42M0.50M8.06M0.04M170.53M43.17M
Additional items
Exchange Rate EffectFX Effect
0.08M-0.74M1.12M0.15M-0.13M-0.06M-0.22M-0.17M-0.34M-0.10M
Change in Cash
-212.21M-26.22M-3.89M36.37M-37.59M-71.03M19.99M-25.67M18.25M-8.14M-0.23M-4.25M5.69M12.25M199.99M-149.07M65.19M-38.70M133.21M-104.84M
Ending Cash Balance
132.42M106.21M102.32M138.69M101.10M30.07M50.07M24.40M42.65M34.51M34.29M30.04M35.72M47.98M247.97M98.90M164.09M125.39M258.60M153.77M
Free Cash FlowFCF
-23.62M-24.94M-27.11M-28.20M-16.23M-19.34M-17.51M-16.18M-15.04M-15.73M-37.32M-31.23M-46.29M-42.70M-48.36M-60.91M-29.82M5.05M-43.25M-40.19M
Net Cash FlowNCF
-212.21M-26.22M-46.05M78.54M-37.59M-71.03M19.99M-25.67M18.25M-8.14M-0.30M-3.51M4.57M12.10M200.12M-149.02M65.42M-38.49M133.52M-104.78M

Nuvation Bio Cash Flow Statement API

Pull Nuvation Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NUVB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY